Project Grant HT94252310949
Award Date
9/30/23
Completion Date
9/29/26
Dollars Obligated
$775K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Louisville, KY 40208, USA
Similar Awards
The University of Louisville Office of Research & Innovation Division was awarded a $1,368,092 Project Grant by the Defense Health Agency under the Department of Defense's Military Medical Research and Development program (CFDA 12.420). The funding supports a 3-year research project investigating the "Liver and Systemic Effects of Toxic Exposures". The research aims to transform healthcare for Service Members and the American public through innovative biomedical research. The...
The University of Louisville received a $873,034 Department of Defense (DOD) federal project grant award under the Military Medical Research and Development program (CFDA 12.420) to conduct research on the "Liver and Systemic Effects of Toxic Exposures". The 3-year grant, awarded on September 30, 2023, supports the University's biomedical research efforts to investigate medical solutions for Service Members and the American public. The DOD program funds a range of studies across...
The University of Louisville was awarded a $696,371 project grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research on "A DIRECT RAS PAN-INHIBITOR AS A NOVEL STRATEGY FOR LUMINAL B BREAST CANCER" from January 15, 2023 through January 14, 2026. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military and...
The University of Louisville's Office of Research & Innovation has been awarded a $766,848 federal Project Grant under the Military Medical Research and Development program (CFDA 12.420) from the Defense Health Agency. This 3-year grant, effective September 1, 2024, will support research to unveil the role of PAF/PTAFR signaling in the lymphatic system of melanoma patients with nodal metastasis. The university will conduct this biomedical research project at its Louisville, Kentucky...
The University of Louisville received a $1,015,291 Project Grant award from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The three-year award will support research from March 2023 to February 2026 to investigate the epigenetic drivers of endocrine-resistant breast cancer. Through this funding, the University will conduct applied biomedical research focused on transforming healthcare and investigating medical solutions for...
The University of Louisville will receive $1.3 million under a three-year Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420). The grant will support research into M6A epitranscriptome drivers of endocrine-resistant breast cancer. Through this funding, the University will investigate medical solutions for breast cancer that has developed resistance to hormone therapies, with the goal of transforming healthcare for both military...
The University of Louisville will receive $1,292,792 under a three-year Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 2022 to September 2025 on "Microbial Dysbiosis and Bacterial Amyloids in Alzheimer's Disease." The Military Medical Research and Development program supports biomedical research to improve health care for service members and the general public. This award will...
The U.S. Department of Defense's Defense Health Agency awarded a $749,999 Project Grant to the University of Louisville's Office of Research & Innovation to support the "RESTORATION OF MACROPHAGE FUNCTION AS A STRATEGY TO PREVENT/TREAT LUPUS" research project. The grant, which runs from September 1, 2023 to August 31, 2026, is funded through the Military Medical Research and Development program (CFDA 12.420). This program supports a range of biomedical research aimed at...
The Defense Health Agency awarded Duke University a $759,627.49 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "ACCELERATED AGING IN GULF WAR ILLNESS: PHENOTYPES, EPIGENETIC BIOMARKERS, AND ASSOCIATIONS WITH GULF WAR EXPOSURES." The project will run from August 1, 2023 to July 31, 2026. Duke University, a top-ranked global research institution, will be the prime awardee and perform the research through its Office of...
The University of Louisville Office of Research & Innovation was awarded a $1,927,512 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to develop dried blood for prolonged field care in austere environments. The award, effective June 15, 2024 through June 14, 2027, will support research and development activities focused on improving medical outcomes for military service members in remote or resource-constrained...